![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Ent. | LSE:HCEG | London | Ordinary Share | GB00B6030H73 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:2708I Healthcare Enterprise Group PLC 07 February 2005 Healthcare Enterprise Group PLC Directors' interests in shares On 4 February 2005 the Company was notified of the following transactions concerning directors' interests in the share capital of the Company, which completed on that day: Michael Low (CEO Advisory Services) exercised options over 400,000 ordinary shares of 2.5p each and sold 400,000 (0.27%) ordinary shares of 2.5p each. He continues to hold 4,804,058 shares and options and warrants over 1,208,709 shares representing 3.36% of the fully diluted share capital. Nicholas Brigstocke (Non-executive Deputy Chairman) exercised options over 400,000 ordinary shares of 2.5p each and sold 400,000 (0.27%) ordinary shares of 2.5p each. He continues to hold 1,037,953 shares and options and warrants over 2,795,404 shares representing 2.14% of the fully diluted share capital. Lyndon Gaborit (Non-executive Director) exercised options over 480,000 ordinary shares of 2.5p each and sold 480,000 (0.32%) ordinary shares of 2.5p each. He continues to hold options and warrants over 3,663,140 shares representing 2.05% of the fully diluted share capital. Kenneth Denos (Non-executive Director) exercised options over 480,000 ordinary shares of 2.5p each and sold 480,000 (0.32%) ordinary shares of 2.5p each. He continues to hold 897,263 shares and options and warrants over 2,798,437 shares representing 2.06% of the fully diluted share capital. Ballerat International Limited, a company which is wholly owned by a trust associated with Mark Tompkins (Non-executive Director), sold 438,162 (0.29%) ordinary shares of 2.5p each. Ballerat International Limited continues to hold 57,350 shares and options and warrants over 2,980,603 shares representing 1.7% of the fully diluted share capital. The sale of shares was effected in order to settle tax liabilities and related expenses. These shares have been placed with institutional investors by Numis Securities Limited. In connection with these share option exercises 850,393 ordinary shares of 2.5p each have been issued. Stuart Bruck (Executive Chairman), Gordon Wood (Group Chief Operating Officer), John Bradshaw (Group Finance Director) and Nigel Wray (Non executive Director) have not exercised options or sold shares. 7 February 2005 Enquiries: Healthcare Enterprise Group 020 7351 7500 John Bradshaw, Finance Director College Hill 020 7457 2020 Nicholas Nelson Corinna Dorward This information is provided by RNS The company news service from the London Stock Exchange END RDSEAPALEEFSEFE
1 Year Healthcare Enterprise Chart |
1 Month Healthcare Enterprise Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions